Leventhal Mark S 4
4 · ProPhase Labs, Inc. · Filed Nov 30, 2012
Insider Transaction Report
Form 4
Leventhal Mark S
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0005
2012-11-28$1.42/sh+47,300$67,166→ 47,300 total(indirect: By Foundation) - Purchase
Common Stock, par value $0.0005
2012-11-29$1.60/sh+102,700$164,320→ 150,000 total(indirect: By Foundation)
Holdings
- 290,195
Common Stock, par value $0.0005
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.4193 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.599 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.